Squibb Corp acquires Chantal Pharmaceutical-Rights from Chantal Pharmaceutical Corp


Squibb acquired marketing rights from Chantal Pharmaceutical for a family of experimental drugs that held promise for treating acne, skin wrinkling and baldness. The amount of the acquisition was not disclosed.

Deal Information

Credit & Investment Research

Market Research

News